Open an account

Health Catalyst

HCAT · NASDAQ

$1.75+$0.04 (+2.34%)TodayMarket closed ·
Prev close $1.71

About HCAT

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.

Employees
0
Headquarters
South Jordan, Utah
Listed
Jul 25, 2019
Sector
Health Care
Industry
Health Care Technology
Website
healthcatalyst.com

HCAT key statistics

Market cap
128.69M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
414.79K
Volume
139.58K
Open price
$1.71
High today
$1.76
Low today
$1.68
52 Week high
$3.62
52 Week low
$0.9551

Health Catalyst (HCAT) at a glance

As of Oct 20, 2026, Health Catalyst (HCAT) shares are priced at $1.75, giving the company a market cap of 128.69M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.68 and $1.76. The current price is 4.1% above the day's low and 0.6% below its high.

Volume so far is 139.58K shares, below the average of 414.79K shares a day.

Over the past year Health Catalyst has ranged from $0.9551 to $3.62, and now sits 30% of the way up that range.

Health Catalyst met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $0.04 per share against an estimate of $0.031.

The average analyst price target is $1.80, 3.0% above the current price, from 6 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 6 analyst ratings say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 5 analystsAvg $1.80
Low
$1.51
Now
$1.75
High
$2.10

HCAT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 114.7% on average.

  1. Q3 FY24: reported $0.07 per share against an estimate of $0.0996
  2. Q4 FY24: reported $0.04 per share against an estimate of $0.0754
  3. Q1 FY25: reported $0.01 per share against an estimate of $0.002
  4. Q2 FY25: reported $0.04 per share against an estimate of $0.0346
  5. Q3 FY25: reported $0.06 per share against an estimate of $0.0604
  6. Q4 FY25: reported $0.08 per share against an estimate of $0.0928
  7. Q1 FY26: reported $0.02 per share against an estimate of $0.0175
  8. Q2 FY26: reported $0.04 per share against an estimate of $0.031

HCAT news

  • Press releasePRNewswire

    Health Catalyst Strengthens Its Board with the Appointment of Tami Reller

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • Tanya Rawat

    Health Catalyst Shares Tumble Overnight: What Investors Need to Know

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releasePRNewswire

    Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

  • Press releasePRNewswire

    Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield

  • Press releasePRNewswire

    Health Catalyst Appoints Ben Albert as Chief Executive Officer

Similar companies

Companies in the same industry as Health Catalyst

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.